NEW YORK--(BUSINESS WIRE)--IRX Therapeutics, a developer of immune therapies to make cancer treatments better, announced today it has signed a research collaboration agreement with one of the world’s leading research-based pharmaceutical companies.
NEW YORK--(BUSINESS WIRE)--IRX Therapeutics, a developer of immune therapies to make cancer treatments better, announced today it has signed a research collaboration agreement with one of the world’s leading research-based pharmaceutical companies.
